Identification of a Prognostic Gene Signature for Chemoresistance Prediction in Lung Adenocarcinoma by Screening Mitochondrial Metabolism Gene Sets
International Journal of Molecular Sciences · 27.03.2026 · 27 (7) · 3065
DOI: 10.3390/ijms27073065 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 27.03.2026. Verfasst von Binbin Tan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Shenzhen University Medical School, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Adenocarcinoma of Lung, Lung Neoplasms, Mitochondria. Die Arbeit nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Stable Support Project of Shenzhen, the Natural Science Foundation of Guangdong Province, the National Natural Science Foundation of China.
Abstract (Originalsprache)
Chemoresistance is a major challenge in lung adenocarcinoma (LUAD) treatment and is associated with mitochondrial metabolism. Using publicly available LUAD transcriptome data, we established a five-gene prognostic signature (YWHAZ, HSPD1, NOTCH3, PGK1, and PPARG) for LUAD through differential gene expression profiling, univariate Cox analysis, and machine learning–based feature selection. Patients with LUAD were classified into a high-risk group (HRG) and a low-risk group (LRG) based on their risk scores. Enrichment analysis revealed significant differences between the HRG and LRG in multiple pathways related to metabolism and immunity. The immune microenvironment also differed significantly between the two groups, and the prognostic genes were correlated with infiltrating immune cells. A total of 110 compounds exhibited differential sensitivity across the groups. Molecular docking demonstrated a favorable binding affinity between the prognostic genes and the predicted drugs. Furthermore, YWHAZ knockdown significantly suppressed cancer cell proliferation in cell and animal models. In addition, YWHAZ knockdown markedly reduced cisplatin resistance by downregulating key regulators of the DNA replication and repair pathway, including POLA1 and MCM4. These results provide insight into the molecular mechanisms underlying chemoresistance and identify putative therapeutic targets for LUAD treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Shenzhen University Medical School, Shenzhen 518055, China.
ORCID-Profile: Binbin Tan, Shanshan Liu
Förderung
- the Stable Support Project of Shenzhen
- the Natural Science Foundation of Guangdong Province
- the National Natural Science Foundation of China
Zitieren
APA
Tan, B., Yang, J., Zhao, X., & Liu, S. (2026). Identification of a Prognostic Gene Signature for Chemoresistance Prediction in Lung Adenocarcinoma by Screening Mitochondrial Metabolism Gene Sets. International Journal of Molecular Sciences, 27(7), 3065. https://doi.org/10.3390/ijms27073065
Vancouver
Tan B, Yang J, Zhao X, Liu S. Identification of a Prognostic Gene Signature for Chemoresistance Prediction in Lung Adenocarcinoma by Screening Mitochondrial Metabolism Gene Sets. International Journal of Molecular Sciences. 2026;27(7):3065. doi:10.3390/ijms27073065
BibTeX
@article{Tan2026,
author = {Tan, Binbin and Yang, Jinxu and Zhao, Xibao and Liu, Shanshan},
title = {Identification of a Prognostic Gene Signature for Chemoresistance Prediction in Lung Adenocarcinoma by Screening Mitochondrial Metabolism Gene Sets},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {7},
pages = {3065},
doi = {10.3390/ijms27073065}
}
EUVIMED